American Tartaric Products Inc, based in U.S.A, is a pharmaceutical company.
One of their notable products is POTASSIUM BITARTRATE, USP/FCC, with a corresponding US DMF Number 29204.
Remarkably, this DMF maintains an Active status since its submission on February 27, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2023, and payment made on December 30, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II